Monoclonal Antibodies as a Tool to Detect Melanoma-Associated Antigens

  • Stefan Carrel
  • Roberto S. Accolla
  • Jean-Pierre Mach
  • Nicole Gross


The existence of common serologically defined tumor-associated antigen(s) on human melanoma cells has been suggested by several studies in which human allogeneic or autologous sera have been used (Gupta and Morton, 1975; Lewis et al., 1979; Carey et al., 1976; Liao et al.,1978; Shiku et al., 1976, 1977; Cornain et al., 1975; Ferrone and Pellegrino, 1977; Hersey et al., 1976; Morton et al., 1968; Muna et al., 1969). In addition, immunization of rabbits, guinea pigs, and monkeys with human melanoma cells has led to the production of several xenoantisera that after absorption reacted preferentially with melanoma cells from primary or long-term cultures (Bystryn, 1977; Carrel et al., 1980a; Fritze et al., 1976; Liao et al., 1979; McCabe et al., 1978; Metzgar et al., 1973; Sorg et al., 1978; Stuhlmiller and Seigler, 1975; Viza and Phillips, 1975). The major drawback of such antisera is, however, the overwhelming number of contaminating antibodies that have to be removed by extensive absorption before any tumor specificity can be demonstrated.


Melanoma Cell Endometrial Carcinoma Melanoma Cell Line Ascites Fluid Culture Fluid 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Accolla, R. S., Carrel, S., and Mach, J.-P., 1980, Monoclonal antibodies specific for carcinoembryonic antigen (CEA) produced by hybrid cell lines, Proc. Natl. Acad. Sci. U.S.A. 77: 563–566.PubMedCrossRefGoogle Scholar
  2. Aubert, C., Lagrange, C., Rorsman, H., and Rosengren, E., 1976, Catecholes in primary and metastatic human malignant melanoma cells in monolayer culture, Eur. J. Cancer 12: 441–445.PubMedGoogle Scholar
  3. Brunner, K. T., Mauel, J., Cerottini, J.-C., and Chappuis, B., 1968, Quantitative assay of the lytic action of immune lymphoid cells on “Cr labeled allogenic target cells in vitro: Inhibition by isoantibody and drugs, Immunology 14: 181–196.PubMedGoogle Scholar
  4. Bystryn, J.-C., 1977, Release of cell-curface tumor-associated antigens by viable melanoma cells from humans, J. Natl. Cancer Inst. 59: 325–328.Google Scholar
  5. Carey, T. E., Takahashi, T., Resnick, L. A., Oettgen, H. F., and Old, L. J., 1976, Cell surface antigens of human malignant melanoma: Mixed hemadsorption assay for humoral immunity to cultured autologous melanoma cells, Proc. Natl. Acad. Sci. U.S.A. 73: 3278–3282.PubMedCrossRefGoogle Scholar
  6. Carrel, S., Delisle, M.-C., and Mach, J.-P., 1977, Antibody dependent cell-mediated cytolysis of human colon carcinoma cells induced by specific antisera against carcinoembryonic antigen, Cancer Res. 36: 2644–2650.Google Scholar
  7. Carrel, S., Gross, N., Heumann, D., and Mach, J.-P., 1979, Expression of “Ia-like” antigens on cells from a human endometrial carcinoma cell line End-1, Transplantation 27: 431–433.PubMedGoogle Scholar
  8. Carrel, S., Dent, P. B., and Liao, S. K., 1980a, Demonstration of the specificity of a monkey antiserum against human melanoma: Evidence that the cytotoxic antibodies from the specific antiserum belong to the IgM class, Cancer Immunol. Immunother. 8: 192–203.CrossRefGoogle Scholar
  9. Carrel, S., Accolla, R. S., Carmagnola, A. L., and Mach, J.-P., 1980b, Common human melanoma associated antigen(s) detected by monoclonal antibodies, Cancer Res. 40: 2523–2428.Google Scholar
  10. Carrel, S., Accolla, R. S., Carmagnola, A. L., and Mach, J.-P., 1980c, Demonstration of human melanoma associated antigen(s) by monoclonal antibodies, in: Protides of Biological Fluids, Vol. 27 (H. Peeters, ed.,), Pergamon Press, Oxford (in apress).Google Scholar
  11. Carrel, S., Tosi, R., Gross, N., Tanigaki, N., Carmagnola, A. L., and Accolla, R. S., 1981, Subsets of human Ia-like molecules defined by monaclonal antibodies Mol. Immunol. 18: 403–411.PubMedCrossRefGoogle Scholar
  12. Cornain, S., De Vries, J. E., Collard, J., Vennegoor, C., van Wingarden, I., and Rumke, P., 1975, Antibodies and antigen expression in human melanoma detected by the immune adherence test, Int. J. Cancer 16: 981–997.PubMedCrossRefGoogle Scholar
  13. Cowan, N. J., Secher, D. S., and Milstein, C., 1974, Intracellular immunoglobulin chain synthesis in non-secreting variants of a mouse myeloma: Detection of inactive light chain messenger RNA, J. Mol. Biol. 90: 697–701.CrossRefGoogle Scholar
  14. Ferrone, S., and Pellegrino, M. A., 1977, Cytotoxic antibodies to cultured melanoma cells in the sera of melanoma patients, J. Natl. Cancer Inst. 58: 1201–1204.PubMedGoogle Scholar
  15. Fritze, D., Kern, D. H., Drogemuller, C. R., and Pilch, Y. H., 1976, Production of antisera with specificity for malignant melanoma, Cancer Res. 36: 458–466.PubMedGoogle Scholar
  16. Gaynor, R., Irie, R., Morton, D., and Herschman, H. R., 1980, 5100 protein is present in cultured human malignant melanomas, Nature (London) 286:400–401.CrossRefGoogle Scholar
  17. Gupta, R. K., and Morton, D. L., 1975, Suggestive evidence for in vivobinding of specific antitumor antibodies of human melanomas, Cancer Res. 35: 58–62.PubMedGoogle Scholar
  18. Herlyn, M., Steplewski, Z., Herlyn, D., and Koprowski, H., 1979, Colorectal carcinoma-specific antigen: Detection by means of monoclonal antibodies, Proc. Natl. Acad. Sci. U.S.A. 76: 1438–1442.PubMedCrossRefGoogle Scholar
  19. Hersey, P., Honeyman, M., Edwards, A., Adams, E., and McCarthy, W. H., 1976, Antigens on melanoma cells detected by leukocyte dependent antibody assay of human melanoma antisera, Int. J. Cancer 18: 546–573.CrossRefGoogle Scholar
  20. Kennett, R. H., and Gilbert, F., 1979, Hybrid myelomas producing antibodies against a human neuroblastoma antigen present on fetal brain, Science 203: 1120–1121.PubMedCrossRefGoogle Scholar
  21. Klinman, N. R., 1972, The mechanism of antigenic stimulation of primary and secondary clonal precursor cells, J. Exp. Med. 136: 241–260.PubMedCrossRefGoogle Scholar
  22. Köhler, G., and Milstein, C., 1975, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature (London) 256: 495–497.CrossRefGoogle Scholar
  23. Köhler, G., Howe, S. C., and Milstein, C., 1976, Fusion between immunoglobulin secreting and non-secreting myeloma cell lines, Eur. J. Immunol. 6: 292–295.PubMedCrossRefGoogle Scholar
  24. Koprowski, H., Steplewski, Z., Herlyn, D., and Herlyn, M., 1978, Study of antibodies against human melanoma produced by somatic cell hybrids Proc. Natl. Acad. Sci. U.S.A. 75: 3405–3409.PubMedCrossRefGoogle Scholar
  25. Lewis, M. G., Ikonopisov, R. L., Nairn, R. C., Phillips, T. M., Fairley, G. H., Bodenham, D. C., and Alexander, P., 1969, Tumour specific antibodies in human malignant melanoma and their relationship to the extent of the disease, Br. Med. J. 3: 547–552.PubMedCrossRefGoogle Scholar
  26. Liao, S. K., Leong, S. P. L., Sutherland, C. M., Dent, P. B., Kwong, P. C., and Krementz, E. T., 1978, Common human melanoma membrane antigens detected by mixed hemadsorption microassay with serum from a patient undergoing immunotherapy with autologous tumor cells, Cancer Res. 38: 4394–4399.Google Scholar
  27. Liao, S. K., Kwong, P. C., Thompson, J. C., and Dent, P. B., 1979, Spectrum of melanoma antigens on cultured human malignant melanoma cells as detected by monkey antibodies, Cancer Res. 39: 183–192.PubMedGoogle Scholar
  28. Lozzio, C. B., and Lozzio, B. B., 1975, Human chronic meylogenous leukemia cell line with positive Philadelphia chromosome, Blood 45: 324–334.Google Scholar
  29. McCabe, R. P., Ferrone, S., Pellegrino, M. A., Kern, D. H., Holmes, E. C., and Reisfeld, R. A., 1978, Purification and immunological evaluation of human melanoma-associated antigens, J. Natl. Cancer Inst. 60: 773–777.PubMedGoogle Scholar
  30. Metzgar, R. S., Bergoc, P. M., Moreno, M. Y., and Seigler, H. F., 1973, Melanoma-specific antibodies produced in monkey by immunization with human melanoma cell lines, J. Natl. Cancer Inst. 50: 1065–1068.PubMedGoogle Scholar
  31. Morton, D. L., Malmgreen, R. A., Holmes, E. C., and Ketcham, A. S., 1968, Demonstration of antibodies against human malignant melanoma by immunofluorescence, Surgery 64: 233–240.PubMedGoogle Scholar
  32. Muna, N. M., Marcus, S., and Smart, C., 1969, Detection by immunofluorescence of antibodies specific for human malignant melanoma cells, Cancer 23: 88–95.PubMedCrossRefGoogle Scholar
  33. Pontecorvo, G., 1975, Production of mammalian somatic cell hybrids by means of polyethylene-glycol treatment, Somatic Cell Genet. 1: 397–400.PubMedCrossRefGoogle Scholar
  34. Schmidt-Ulrich, R., Ferber, E., Kneufermann, H., Fischer, H., and Hoelzl-Wallach, D. F., 1974, Analysis of the proteins in thymocyte plasma membrane and smooth endoplasmic reticulum by sodium dodecyl-sulfate gel electrophoresis, Biochim. Biophys. Acta 332: 175–191.CrossRefGoogle Scholar
  35. Schnegg, J. F., Diserens, A. C., Carrel, S., and de Tribolet, N., 1981, Human glioma-associated antigens detected by monoclonal antibodies, Cancer Res. 41: 1209.PubMedGoogle Scholar
  36. Shiku, H., Takahashi, T., Oettgen, H. F., and Old, L. J., 1976, J. Exp. Med. 144: 873–881.PubMedCrossRefGoogle Scholar
  37. Shiku, H., Takahashi, T., Oettgen, H. F., and Old, L. J., 1977, Cell surface antigens of human malignant melanoma. III. Recognition of auto-antibodies with unusual characteristics, J. Exp. Med. 145: 784–789.PubMedCrossRefGoogle Scholar
  38. Sorg, C., Brüggen, J., Seibert, E., and Macher, E., 1978, Membrane-associated antigens of human malignant melanoma. IV. Changes in expression of antigens on cultured melanoma cells, Cancer Immunol, Immunother. 3: 259–271.CrossRefGoogle Scholar
  39. Steplewski, Z., Herlyn, M., Herlyn, D., Clark, W., and Koprowski, H., 1979, Reactivity of monoclonal anti-melanoma antibodies with melanoma cells freshly isolated from primary and metastatic melanoma, Eur. J. Immunol. 9: 94–96.PubMedCrossRefGoogle Scholar
  40. Stuhlmiller, G. M., and Seigler, H. F., 1975, Characterization of a chimpanzee anti-human melanoma antiserum, Cancer Res. 35: 2132–2137.PubMedGoogle Scholar
  41. Viza, D., and Phillips, J., 1975, Identification of an antigen associated with malignant melanoma, Int. J. Cancer 16: 312–317.PubMedCrossRefGoogle Scholar
  42. Williams, A. F., 1977, Differentiation antigens of the lymphocyte cell surface, in: Contemporary Topics in Molecular Immunology, Vol. 6 ( G. L. Ada and R. R. Porter, eds.), pp. 93–116, Plenum Press, New York.Google Scholar
  43. Wilson, B. S., Indiveri, F., Pellegrino, M. A., and Ferrone, S., 1979, DR. (Ia-like) antigens on human mela- noma cells: Serological detection and immunochemical characterization, J. Exp. Med. 149: 658–668.PubMedCrossRefGoogle Scholar
  44. Winchester, R. J., Wang, C., Gibofsky, A., Kunkel, H. G., Lloyd, K. O., and Old, L. J., 1978, Expression of Ia-like antigens on cultured human malignant melanoma cells lines, Proc. Natl. Acad. Sci. U.S.A. 75: 6235–6239.PubMedCrossRefGoogle Scholar
  45. Woodbury, R. G., Brown, J. P., Yeh, M. X., Hellström, I., and Hellström, K. G., 1980, Identification of a cell surface protein, P97, in human melanomas and certain other neoplasms, Proc. Natl. Acad. Sci. U.S.A. 77: 2183–2187.PubMedCrossRefGoogle Scholar
  46. Yeh, M. Y., Hellström, I., Brown, J. P., Warner, G. A., Hansen, J. A., and Hellström, K. E., 1979, Cell surface antigens of human melanoma identified by monoclonal antibody, Proc. Natl. Acad. Sci. U.S.A. 76: 2927–2931.PubMedCrossRefGoogle Scholar
  47. Zardi, L., Carnemolla, B., Siri, A., Santi, L., and Accolla, R. S., 1980, Somatic cell hybrids producing antibodies specific to human fibronectin, Int. J. Cancer 25: 325–328.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • Stefan Carrel
    • 1
  • Roberto S. Accolla
    • 1
  • Jean-Pierre Mach
    • 1
  • Nicole Gross
    • 1
  1. 1.Unit of Human Cancer Immunology, Lausanne BranchLudwig Institute for Cancer ResearchEpalingesSwitzerland

Personalised recommendations